Return Policy

Customer satisfaction is our #1 priority. If you don’t find relief with use as directed for 60 days, just send us a copy of your cash register receipt and UPC code, along with your full name and address, and we will refund your purchase:

Lipo-Flavonoid Refund
138 East Main Street
Suite 201A
Kent, OH, 44240

Limit one refund per household. Refunds will be issues for the full purchase price minus shipping (where applicable).

For questions regarding a return or refund, please call our Customer Service at (844) 454-7632

Shipping Policy:

Free standard shipping is provided for orders shipped within the Continental United States. For orders outside of the Continental United States or for express shipping, prices are listed during the check-out process, based on zip/postal code.

Payment Policy:

We accept the following major credit cards: Visa, MasterCard, American Express and Discover.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

*Survey data on file

REFERENCES:

  1. April 2018 Survey. Clarion Brands Inc. data on file.
  2. Williams H, Hedgecock L. Citrus Bioflavonoids, Ascorbic Acid and Other B-vitamins in the Treatment of certain types of neurosensory deafness a preliminary report. Staff meeting of the Mayo Clinic (1962).
  3. Tinnitus Overview. Mayo Clinic website http://www.mayoclinic.org/diseases-conditions/tinnitus/basics/definition/con-20021487. Accessed Sept. 7, 2016.
  4. Understanding the Facts. American Tinnitus Associations website https://www.ata.org/understanding-facts. Accessed Sept. 7, 2016.
  5. Slattery WH, Fayad JN. Medical treatment of Meniere's disease. Otolaryngologic Clinics of North America 1997; 30:1027-37.
  6. Kumar S, Pandey AK. Chemistry and Biological Activities of Flavonoids: An Overview. The Scientific World Journal. 2013;2013:162750. doi:10.1155/2013/162750.
  7. Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996; 17:529-36.
  8. Arenberg I, Bayer R. Therapeutic Options in Meniere’s Disease. Arch Otolaryngol 1977;103: 589-93.
  9. Shaia F, Sheehy J. Sudden sensori-neural hearing impairment: a report of 1,220 cases. Laryngoscope 1976; 86:389-98.
  10. Herschberg S. Meniere’s disease. J Am Osteopathic Association 1974; 73:540-6.
  11. Wolfson R. Treatment of Meniere’s disease. Modern Treatment (1969) 6,3, 553-567.
  12. Rubin W. Vestibular suppressant drugs. Arch Otolaryngol 1973; 97:135-8